Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Cogent Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +22 vs. Q2 2022
- Shares held
- 74.4M
- +4.09M (+5.8%) vs. Q2 2022
- Total value
- $1.10B
- +$469.8M (+74.2%) vs. Q2 2022
- New holders
- 35
- 46 more added
- Sold out
- 13
- 36 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $7.50B |
| Q1 2026 | 305 | $7.17B |
| Q4 2025 | 267 | $6.18B |
| Q3 2025 | 195 | $2.29B |
| Q2 2025 | 181 | $973.2M |
| Q1 2025 | 186 | $799.6M |
| Q4 2024 | 177 | $949.5M |
| Q3 2024 | 161 | $1.32B |
| Q2 2024 | 149 | $1.02B |
| Q1 2024 | 146 | $734.3M |
| Q4 2023 | 144 | $534.0M |
| Q3 2023 | 135 | $885.8M |
| Q2 2023 | 136 | $1.05B |
| Q1 2023 | 137 | $810.4M |
| Q4 2022 | 135 | $864.1M |
| Q3 2022 | 134 | $1.10B |
| Q2 2022 | 112 | $633.3M |
| Q1 2022 | 86 | $353.6M |
| Q4 2021 | 82 | $385.2M |
| Q3 2021 | 73 | $309.6M |
| Q2 2021 | 69 | $293.7M |
| Q1 2021 | 69 | $303.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Cogent Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Platinum Investment Management Ltd | 511,390 | $7.63M | 0.32% | −390,022−43.3% | Reduced |
| Northern Trust Corp | 535,603 | $7.99M | 0.00% | +179,678+50.5% | Added |
| Morgan Stanley | 565,119 | $8.43M | 0.00% | +287,972+103.9% | Added |
| Ghost Tree Capital, LLC | 600,000 | $8.95M | 3.66% | −300,000−33.3% | Reduced |
| Silverarc Capital Management, LLC | 606,608 | $9.05M | 3.84% | −214,346−26.1% | Reduced |
| Goldman Sachs Group Inc | 741,988 | $11.1M | 0.00% | +372,063+100.6% | Added |
| 5AM Venture Management, LLC | 790,440 | $11.8M | 2.26% | −338,760−30.0% | Reduced |
| D. E. Shaw & Co., Inc. | 900,073 | $13.4M | 0.02% | +704,172+359.5% | Added |
| Kynam Capital Management, LP | 985,155 | $14.7M | 3.11% | −14,845−1.5% | Reduced |
| Assenagon Asset Management S.A. | 988,636 | $14.8M | 0.06% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 1,049,542 | $15.7M | 0.06% | −51,761−4.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,146,650 | $17.1M | 0.04% | −80,000−6.5% | Reduced |
| Candriam Luxembourg S.C.A. | 1,151,502 | $17.2M | 0.12% | −99,387−7.9% | Reduced |
| Geode Capital Management, LLC | 1,174,760 | $17.5M | 0.00% | +436,836+59.2% | Added |
| FMR LLC | 1,299,043 | $19.4M | 0.00% | +44,693+3.6% | Added |
| Citadel Advisors LLC | 1,332,280 | $19.9M | 0.02% | +260,766+24.3% | Added |
| Avidity Partners Management LP | 1,357,700 | $20.3M | 0.44% | +1,357,700 | New |
| Cormorant Asset Management, LP | 1,450,000 | $21.6M | 1.52% | +700,000+93.3% | Added |
| Janus Henderson Group PLC | 1,688,529 | $25.2M | 0.02% | −441,967−20.7% | Reduced |
| Suvretta Capital Management, LLC | 1,862,600 | $27.8M | 1.17% | +1,262,600+210.4% | Added |
| Vivo Capital, LLC | 1,883,941 | $28.1M | 3.10% | −37,000−1.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 2,074,154 | $30.9M | 2.38% | −20,000−1.0% | Reduced |
| BVF Inc | 2,084,824 | $31.1M | 1.28% | −172,350−7.6% | Reduced |
| Fairmount Funds Management LLC | 2,758,975 | $41.2M | 7.59% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 2,860,892 | $42.7M | 0.84% | −2,234,108−43.8% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 2,966,345 | $44.3M | 0.88% | −2,910,460−49.5% | Reduced |
| Vanguard Group Inc | 3,183,770 | $47.5M | 0.00% | +597,966+23.1% | Added |
| Perceptive Advisors LLC | 3,207,441 | $47.9M | 1.39% | +118,469+3.8% | Added |
| State Street Corp | 3,408,602 | $50.9M | 0.00% | +2,714,447+391.0% | Added |
| TCG Crossover Management, LLC | 3,481,042 | $51.9M | 15.58% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,013,453 | $59.9M | 1.28% | +4,013,453 | New |
| VR Adviser, LLC | 4,038,117 | $60.2M | 9.30% | 00.0% | Unchanged |
| Commodore Capital LP | 4,319,940 | $64.5M | 10.36% | −624,768−12.6% | Reduced |
| BlackRock Inc. | 4,596,303 | $68.6M | 0.00% | +1,299,523+39.4% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −1,625,817−100.0% | Sold out |
| Atlas Venture Associates IX, LLC | 0 | $0 | 0.00% | −466,832−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −447,634−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −238,787−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −235,500−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −146,911−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −30,063−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −16,380−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −11,615−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −7−100.0% | Sold out |